Adult Growth Hormone Deficiency and Cardiovascular Risk
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This protocol will assess the cardiovascular risk associated with growth hormone deficiency
in adults. We will use multiple modalities to assess risk for heart attacks or strokes
including blood work, ultrasound, MRI and endothelial cell biopsies in both patients who are
growth hormone deficient and in patients with normal growth hormone secretion. We hypothesize
that adults with growth hormone deficiency will have results suggestive of an increased risk
for cardiovascular disease.